Skip to main content
Download PDF

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

BMC Psychiatry volume 18, Article number: 389 (2018) Cite this article

The Original Article was published on 14 November 2018

Correction to: BMC Psychiatry (2018) 18:365

https://0-doi-org.brum.beds.ac.uk/10.1186/s12888-018-1946-x

Following publication of the original article [1], the authors notified us that the color labelling in Fig. 4 was incorrect.

The corrected Fig. 4 is presented below.

Fig. 4
figure 1

Effects of AOM treatment on Brief Psychiatric Rating Scale (BPRS), global score (values of all items added up) in patients ≤35 years or > 35 years. 18: symptoms not present, 126: symptoms extremely severe. Error bars represent standard deviations

Full size image

Reference

  1. Schöttle, et al. Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study (2018). 2018;18:365. https://0-doi-org.brum.beds.ac.uk/10.1186/s12888-018-1946-x.

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie und Psychotherapie, Zentrum für Psychosoziale, Medizin, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20, ,246, Hamburg, Germany

    Daniel Schöttle, Daniel Luedecke & Klaus Wiedemann

  2. Lundbeck GmbH, Ericusspitze 2, 20, ,457, Hamburg, Germany

    Wolfgang Janetzky

  3. ANFOMED GmbH, Röttenbacher Str. 17, 91,096, Möhrendorf, Germany

    Elmar Beck

  4. Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, 75–59 263rd St, Glen Oaks, NY, 11004, USA

    Christoph U. Correll

  5. Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, 500 Hofstra Blvd, Hempstead, NY, 11549, USA

    Christoph U. Correll

  6. Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Augustenburger Platz 1 (Mittelallee 5A), 13, ,353, Berlin, Germany

    Christoph U. Correll

Authors
  1. Daniel Schöttle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Janetzky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Luedecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elmar Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christoph U. Correll
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Klaus Wiedemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Schöttle.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schöttle, D., Janetzky, W., Luedecke, D. et al. Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study. BMC Psychiatry 18, 389 (2018). https://0-doi-org.brum.beds.ac.uk/10.1186/s12888-018-1968-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12888-018-1968-4

BMC Psychiatry

ISSN: 1471-244X

Contact us